Informed consent in uremia therapy.
Decision making in uremia therapy requires that patients be provided with a fair assessment of their course if untreated or if managed by any of several acceptable alternatives. Enthusiastic overselling of any treatment or intimidation of patients to accept a local regimen is unacceptable practice. Suiting patient to treatment requires time, patience, an acceptance of the patient as a partner in evaluating options.